![](/img/cover-not-exists.png)
The use of doxorubicin is a risk factor for the incidence of acute pancreatitis after liver embolization/transartherial chemoembolization
Valente, Roberto, Piciucchi, Matteo, Signoretti, Marianna, Zerboni, Giulia, Marignani, Massimo, Rossi, Michele, Delle Fave, Gianfranco, Capurso, GabrieleVolume:
14
Language:
english
Journal:
Pancreatology
DOI:
10.1016/j.pan.2014.05.706
Date:
June, 2014
File:
PDF, 65 KB
english, 2014